Agilon Health (AGL) Cash & Equivalents (2020 - 2025)
Historic Cash & Equivalents for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $171.7 million.
- Agilon Health's Cash & Equivalents rose 1587.66% to $171.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.7 million, marking a year-over-year increase of 1587.66%. This contributed to the annual value of $188.2 million for FY2024, which is 7498.47% up from last year.
- Latest data reveals that Agilon Health reported Cash & Equivalents of $171.7 million as of Q3 2025, which was up 1587.66% from $171.4 million recorded in Q2 2025.
- In the past 5 years, Agilon Health's Cash & Equivalents ranged from a high of $1.1 billion in Q2 2021 and a low of $105.3 million during Q1 2021
- Its 5-year average for Cash & Equivalents is $418.0 million, with a median of $188.2 million in 2024.
- In the last 5 years, Agilon Health's Cash & Equivalents surged by 87386.49% in 2021 and then crashed by 7688.17% in 2023.
- Over the past 5 years, Agilon Health's Cash & Equivalents (Quarter) stood at $1.0 billion in 2021, then crashed by 55.26% to $465.3 million in 2022, then crashed by 76.88% to $107.6 million in 2023, then soared by 74.98% to $188.2 million in 2024, then dropped by 8.79% to $171.7 million in 2025.
- Its Cash & Equivalents stands at $171.7 million for Q3 2025, versus $171.4 million for Q2 2025 and $136.9 million for Q1 2025.